Mali gnant melan oma of the nose and paranasal sinuses can be a devastatin g disease, typi cally presentin g at an advanced stage, with a 5-year survival rate ranging between 20 and 30%. It is an uncomm on pro cess, often misd iagnosed bo th clinically and path ologically. We p resent the case of an 80 -year-old man who had a 2-month history ofp rogressively worsening left-sid ed epistaxis and nasal obstruction. Radiographic evidence indica ted the p resence of soft tissu e in the left max illa ry sinus and nasal cavity resembling ma ssive nasal polyp osis and chronic fun gal sinusitis. Ma gnetic resonance imaging was not p erform ed because the patient had a pacemaker: After endoscopic debridement ofthe soft-tissue mass.fro zen-section analysis detected no evidence oftum or: The fi nal pathologic dia gnosis was malignant melan oma. Otolaryngologists sho uld be fa miliar with the difficulties inherent in the dia gnosis and management of sinonasal melan oma s.
Introduction
Most malignant melanomas are found on the skin, and approximately 20% of skin melanomas are found in the head and neck region.' Primary mucosal melanomas of the nasal cavity and paranasal sinuses are rare. First described by Lucke in 1869, melanoma of the nasal cavity and paranasal sinuses is estimated to account for less than I% of all malignant melanomas and 2 to 8% of malignant neoplasms of the sinonasal tract. ' The diagnosis of paranasal sinus melanoma is fraught with difficult y,especially when a lesion lacks pigmentation, which occ urs in more than one-third of cases .I Signs and symptoms of parana sal sinus melanom as can be confu sed with those of nasal polyposis and chronic sinusitis.Intraopera tive frozen-section diagnosis of melanoma is difficult to make, as special staining and immunochemistry are often required . We present a case of malignant melanoma that origi nated in the left maxillary sinus and masqueraded as chronic sinusitis and nasal polyposis.
Case report
An 80-yea r-old man was referred to our office with a 2-month history of intermittent left-sided epistaxis. His bleeding had been severe enough to require hospitalization for cauterization and transfusion. At presentation, the patient also complained of dim inished olfaction, left-sided facial pressure, and nasal obstruction. He denied experiencing paresthesias, headaches, or visual change s. He had a history of cardiac disease, which had required the placement of a pacemaker. He did not smoke and drank alcohol only occasionally.
Physic al examination revea led the presence of clotted blood in the left nasal cavity and obstruction with friable tissue in the left middle meatus. Computed tomography (CT) demonstrated a soft-tissue density in the left maxillary sinus, expansion of the medial wall of the maxilla, obstruction of the middle meatus, and opacification of the ethmoid sinus (figure I). Because of the pacemaker, the patient co uld not undergo magnetic resonance imaging (MRI). He was admitted with a diagnosis of epistaxis with a left-sided nasal mass.The differential diagnosis included carc inoma, fungal sinusitis, papilloma, and chronic sinusitis with nasal polyposis. He was prepared for endoscopic biopsy and control of epistaxis.
In the operating room, the endosco pic examination detected clotted blood in the left nasal cavity; the blood was removed endoscopically. A middl e-meatal antrostomy revealed another large quantity of clotted blood in the maxillary antrum, which was also removed endoscopically. On gross inspection, the mucosa exhibited a mark ed amount of polypoid change, consistent with www.entjournal.com· 561 Figure 1. Axial (A) and coronal (B) CT shows the soft-tissue density in the lef t maxillary sinus. The medial wall of the maxilla is expanded, the middle meatus is obstructed, and the ethmoid sinus is opac ified. chroni c sinusitis. Frozen-section examinati on detected no evidence of tumor. An ethmoidectomy was also performed .
Three specimens were submitted. Grossly, the samples were dark red, yellow, and tan-brown soft-tissue masses. The largest measured 6 x 5 x 1.8 em ; the volume of the specimens totaled 64 ern", Microscopically, they demon strated mostly blood clot, organized hemorrhage, and necrotic tissue. Malignant spindlecell foci were noted in a few locations, many containing pigment consistent with melanin ( figure  2 ). Immunohistochemically, the specimen showed negative staining for HMB-45 and melan-A and positive staining for S-I 00 protein, favorin g a diagnosis of ma lignant melanoma.
At a follow-up visit 3 weeks after surgery, dry crusts in the maxillar y and ethmoid regions were noted on endoscopic examination. Staging studies were obtain ed. Residual malignant melanoma was presumed to be present, and staging studies were ordered. Positron-emi ssion tomograph y (PET) demonstrated no definiti ve evidenc e of tumor uptake , and CT of the chest and abdomen showed no evidence of distant metastases. Repeat CT of the sinuses showed moder ate residual soft-tissue density within the left maxillary antrum.
Twelve days later, a repeat endoscopic examination in the operating room detected a granular mass involving the left maxillary antro stomy. Otherwise, no evidence of tumor or infect ion was seen.A gingival-buccal sulcus incision was made, and the maxill ary antrum was entered via a Caldwell-Luc approach, revealing muco sal thicken ing with a granu lar change involvin g the medial wall of the maxilla. Frozen sections obtained from this area showed no evidence of tumor.The patient then underwent a medial maxillectomy.
On pathologic examinati on, no evidence of tumor was seen in any of the specimens; the medial maxilla exhibited chronic inflamm ation and necrosis but no evidence of tumor. S-IOO protein staining was negative for occult foci of melanoma.
The patient completed a course of radiation therapy and was followed with serial examinations in the office. Two years following treatment, he continu es to do well, with no signs of recurrence.
Discussion
While sinonasal malign ant melanoma more often originates in the nasal cavity than the paranasal sinuses,' in many ways this case is fair ly repre sentative of malignant melanomas 562 • www.entjournal.com originatin g in a paranasal sinus. The most common sinus involved is the maxill ary sinus.' Present ing symptoms often include epistaxis and nasal obstruction.' Signs and symptoms indicative of later-stage disease include ( I) diplopia or vision loss from orbital or optic nerve invasion, (2) epiph ora from nasolacrimal duct obstruction, (3) facial swelling and malocclu sion from bone destruction and invasion into the soft tissues of the mouth or face, (4) trismus from invasion of the pterygoid muscles, (5) development of a neck mass from local metastases, (6) hearing loss from serous otitis, and (7) facial numbne ss from invasion of the trigeminal nerve.' Our case was unusual in that the patient presented at a relatively early stage, as most cases of sinus melanoma are diagnosed at a more advanced stage.'
The differential diagnosis of a sinonasal mass includes benign neoplasms, intermed iate neoplasms, and malignant neoplasms.' Benign neop lasms include nasal polyps , osteomas and chondromas, schwannomas and neurofibromas, ossifying fibromas and cementomas, and odontogenic tumor s.' Neopla sms classified as intermediate include inverted papillomas, menin giomas, heman giomas, and hernangiopericytom as.' Squamous cell carcinoma is the most common malignant neoplasm, foll owed by adenoid cystic carcinoma and adenocarcinoma, as well as olfactory neuroblastoma, sarcoma, lymphoma,plasmacytoma, smallcell undifferenti ated carcinoma, and melanoma.l-'
The diagnostic workup for a sinonasal mass includes CT and MRI. Because of our patient's pacemaker, we were not able to use MRI to visualize the mass before surgery but rather were obliged to use CT. MRI is generally viewed as superior to CT for the diagnosis of melan oma . On CT, melanomas and other paranasal sinus tumors can be difficult to distinguish from fluid or other soft-tissue masses. On MRI , it is much easier to distingui sh fluid from soft tissue. Also imaging and hypointense on T2-weighted imaging. This pattern is specific to melanoma and only appears in tumors with abundant melanin pigment .' In our case , MRI would have helped establish a diagnosis of a malignant neoplasm such as melanoma.
Sinus melanoma tumors are usually pigmented with abundant intracytoplasmic melanin, but diagnosis can be difficult since more than one-third of mucosal melanomas Volume 86, Number 9 lack pigment entirely (amelanotic melanoma).' Microscopically, the spindle-cell pattern in melanoma may be confused with that of sarcoma or spindle-cell carcinoma. Similarly, amelanotic spindle-cell melanoma is frequently confused with fibrosarcoma or malignant schwannoma, and epithelioid and pleomorphic patterns of melanoma may be mistaken for carcinoma.' For these reasons, diagnosis is most reliably established by immunohistochemical techniques. S-lOO protein is a sensitive but nonspecific melanoma marker, while HMB-45, a monoclonal antibody derived from melanoma extract, is more specific but may occasionally be detected in carcinoma cells.' For cases in which staining for these two markers yields unclear results, a melanoma-specific marker known as melan-A is typically used. Melan-A has been shown to be highly specific in differentiating melanoma from other malignancies for which it may be confused on light microscopy, such as sarcomas, plasmacytomas, and carcinomas.'
The frozen-section diagnosis of melanoma presents many more challenges. There are reports in the literature about the value of frozen-section analysis of sentinel lymph nodes in cutaneous melanomas, but there are none regarding melanomas in the paranasal sinuses. A study from the Netherlands published in 2000 found that frozen-section analysis (using hematoxylin and eosin [H&E] staining) of sentinel lymph nodes in patients with cutaneous melanoma had a 100% specificity but only a 38% sensitivity, leaving a high percentage of false negatives. ' A larger study from New York published in 2002 showed that frozen-section analysis with H&E staining of sentinel lymph nodes in cutaneous melanomas had a specificity of 100% and a sensitivity of 59% .6 All confirmation of melanoma in both studies was done with immunohistochemical staining.
There is a more recent report on using rapid immunohistochemistry to stain intraoperatively for Sol 00, HMB-45, and a "melanoma cocktail" consisting of HMB-45, melan-A, and tyrosinase.' Although this test added 20 to 25 minutes to the analysis, it resulted in higher sensitivities, ranging from 71 to 86%, while maintaining high specificity.' However, because of its relati ve unavailability, rapid immunohistochemistry for melanoma is not widely performed.
In our case, not surprisingly, attempts at frozen-section analysis to rule out a malignancy were fruitless , as all frozen sections from the initial surgery were falsely negative for malignancy, not to mention melanoma. What makes frozensection diagnosis even more difficult for paranasal sinus melanoma is the relative rarity of the disease-it is seldom high on the differential for a paranasal sinus mass. Also, in the face of bleeding, as was the case here, hemoglobin is converted to a brown pigment, hemosiderin, which is difficult to distinguish from melanin, even in optimal permanent sections. When spindle cells with pigment are seen, they are most commonly caused by fibroblasts and www.entjournal.com • 563 hemo siderin, not mel anom a. In fact, in our case mostofthe pigmented spindle cell s were fibrobl asts and hemo siderin ; a smaller population of spindle cells was found to contain melanin after proper immunohistoch emical stains.
There is no uni versally accepted stag ing sys tem for paranasal sinus melanoma within the TNM staging sys tem, largely because of the rarity of muc osal melanomas. Mo st clinici ans use a simplified three-stage sys tem: stage I for localized disease, stage II for lymph node metastases,"and stage III for distant metastases. However, researchers at the Armed Forces Institute of Pathology publi shed a proposed staging system for sinonasal tract and nasopharyngeal melanoma in 2003 in which TI represents a primary tumor at a single anatomic site, T2 represents a primary tumor at two or more sites, N I represents any lymph node metastasis, and M I represent s any distant meta stasi s."In our case, only one anatomic site was involved (the maxillary sinu s), and PET and CT showed no evidence of lymph node or distant metastases, indic ating a stage I neopl asm according to this system."
It is generally agreed that the mainstay of treatm ent is surgical resection of the tumor with clear margins.r ? Compared with squamous cell carcinoma, paranasal sinus melanoma met astasizes less frequently to cervi cal lymph node s but more frequently to the lung s and the brain. ' Therefore, a neck dissecti on is not recommended for patients without clin ical or rad iologic evidenc e of cer vical metastases." Accordingly, this was the treatment employed in our case.
On follow-up examination of our patient, the conc ern that the excision margins were not adequate to remove the entirety of the tumor was great enough that a second exploration was deemed necessary I month after the original surgery. Although no immunohistochemical evidence of residual tumor was found at that time, few would argue against the prudence of such a procedure when weighed aga inst the dire consequences ofpossibly failing to remove residual tumor, especially in the case of a tumor with such aggressive metastatic potential.
Whil e complete resection of the muco sal melanom a tumor is generally the goal in the absence of distant metastases, it should be noted that more than half of patients in whom local control is achieved after surgery ultim atel y develop distant met astases," Thi s is largel y bec ause it is difficult to secure histolo gicall y disease-free margins in the affec ted anatomic areas.' For this reason, some authors have investigated the use of radiation ther apy after the resection of a mucosal melanoma , even thou gh this tum or was traditionally believed to be radioresistant. " Whil e the evidence is currently under deb ate in the literature, man y now believe this adjuvant therapy to be of benefit in preventing recurrence and ultimately prolonging survival."
With regard to prognosis, the 5-year survival rate for sinonasal melanoma has been reported to range from 20 to 30%.1 A study by Patel et al at Memorial Sloan-Ket-564· www.entjournal.com terin g Cancer Center in New York City revealed a 5-year disease-specific survival rate of 47 % (n = 35).9 Mor e imp ort antl y, four ind ependent predictors of outcome were determined in this study: clinic al stage at presentation , tumor thickness (±5 mm), the pre sence or absence of vascular invasion on histol ogic examination, and the pre senc e or absence of distant metastasis." Because our patient had stage I disease, scant malignant cell foci of small thickn ess, no rep ort of vascular inva sion, and no current distant metastasis, he appe ars to have a relati vely good prognosis compared with that of the average patient with sinonasal melanoma.
In conclusion, melanoma of the paranasal sinus can be a devastating disease.Therefore, otolaryngologists should maintain a high index ofsuspicion when evaluating unusual cases of chronic sinu sitis or nasal polyposis-especially when they are associated with epistaxis or unilateral disease. Howe ver, even then, diagno sis can be exceedingly difficult. MRI is an extremely useful tool in the diagnosis of paranasal sinus melanoma, but when it is unavailable or contra indicated, the diagno sis becomes even more ch allen ging.
About one-third of sinus melanoma s are unpigmented, and the sensitivity offrozen-secti on analysis ofmelanomas is low, especially when bleeding causes fal se negatives. Appropriate immunohistochemical studies of all spindlecell neoplasms should be per formed to establish or exclud e this diagno sis. We believe that the best therapy for paran asal sinus melanoma (in the abse nce of meta sta sis) is co mplete surgica l exci sion followed by a course of radiati on therapy.
